iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th
NASHUA,
N.H. (November 6, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader
providing innovative cancer detection and therapy solutions, today announced that it will
release financial results for the third quarter and nine months ended September
30, 2018 after the close of the market and host a conference call at 4:30pm
Eastern Time on Tuesday, November 13th.
Tuesday, November
13th @ 4:30 pm Eastern Time
Domestic: 888-599-8686
International: 323-994-2093
Conference ID: 1529049
Webcast: http://public.viavid.com/index.php?id=131972
Replays
available through November 27th:
Domestic: 844-512-2921
International: 412-317-6671
Replay
PIN: 1529049
In
addition, a replay of the call will remain on the Company’s website (www.icadmed.com)
until the Company releases its fourth quarter and year ended 2018 financial
results.
About iCAD, Inc.
Headquartered in Nashua, NH,
iCAD is a global medical technology leader providing innovative cancer
detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media
Inquiries:
ARPR,
on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
or
Investor
Relations:
LifeSci
Advisors
Jeremy
Feffer
(212)
915-2568